InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by GLENN JOHN, Chief Financial Officer. Officer active across 2 companies, notably Ekso Bionics Holdings, INC.. Aggregated, 8 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €137k. History available since 17 February 2022. The latest transaction was disclosed on 2 December 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
8 of 8 declarations
John Glenn is the Chief Financial Officer at Ekso Bionics Holdings, Inc. He is responsible for the company's financial management, overseeing accounting and financial operations. His role is essential in ensuring financial transparency and compliance with regulations.